CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13D/A Stake Beneficial Ownership Report
- 4 Planned sale PRESIDENT AND CEO sold 12,000 shares at an average $24.92 ($299,073)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 1,270 shares at $24.80 ($31,497)
- 4 Planned sale CHIEF OPERATING OFFICER sold 50,000 shares at an average $25.06 ($1,252,826)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,000 shares at $25.07 ($75,195)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 12,000 shares at $22.89 ($274,736)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 4,250 shares at an average $22.57 ($95,922)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale PRESIDENT AND CEO sold 12,000 shares at an average $21.66 ($259,902)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 1,270 shares at $21.48 ($27,278)
Page 18 of 40 · 798 filings